Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B.

Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B.

Item
http://www.wikidata.org/entity/Q33718935
Nucleoside/nucleotide analogues in the treatment of chronic hepatitis BComparison of efficacy and safety of tenofovir and entecavir in chronic hepatitis B virus infection: a systematic review and meta-analysisDecreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatmentCost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China.Treatment strategies using adefovir dipivoxil for individuals with lamivudine-resistant chronic hepatitis B.Dynamic Changes of Treg and Th17 Cells and Related Cytokines Closely Correlate With the Virological and Biochemical Response in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogues Treatment.Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis.Improvement in liver histology among Asian patients with chronic hepatitis B after long-term treatment with entecavir.Do different lamivudine-resistant hepatitis B genotypes carry the same risk of entecavir resistance?Prevention and management of drug resistant hepatitis B virus infections.Severe acute hepatitis B in a treatment-naïve patient with antiviral drug resistant mutations in the polymerase gene.Hepatitis B e antigen predicts delayed reduction of HBV DNA without viral breakthrough with adefovir dipivoxil and lamivudine: a 5-year study of patients with hepatitis B with lamivudine resistance.Mild-to-Moderate Elevation of Alanine Aminotransferase Increases Liver Stiffness Measurement by Transient Elastography in Patients With Chronic Hepatitis B
P2860

Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B.

Item
http://www.wikidata.org/entity/Q33718935
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Efficacy and resistance of ent ...... efractory chronic hepatitis B.
@ast
Efficacy and resistance of ent ...... efractory chronic hepatitis B.
@en
type
label
Efficacy and resistance of ent ...... efractory chronic hepatitis B.
@ast
Efficacy and resistance of ent ...... efractory chronic hepatitis B.
@en
prefLabel
Efficacy and resistance of ent ...... efractory chronic hepatitis B.
@ast
Efficacy and resistance of ent ...... efractory chronic hepatitis B.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Efficacy and resistance of ent ...... efractory chronic hepatitis B.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P932